You can buy or sell SAGE and other stocks, options, ETFs, and crypto commission-free!
Sage Therapeutics, Inc. Common Stock, also called Sage Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Read More Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. The listed name for SAGE is Sage Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 10, Pre-Market